Journal
/
/
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Journal JoVE
Immunologie et infection
This content is Free Access.
Journal JoVE Immunologie et infection
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
DOI:

12:43 min

January 06, 2014

, , , , , , , , ,

Chapitres

  • 00:05Titre
  • 02:12ALDEFLUOR Staining
  • 04:45Preparation of Cancer Stem Cell Lysate-pulsed Dendritic Cell (CSC-TPDC) Vaccine
  • 07:11Vaccination and Evaluation of the Efficacy
  • 09:07Results: CSC-TPDC Vaccination Significantly Inhibits Murine Tumor Growth Activity
  • 12:07Conclusion

Summary

Traduction automatique

Evaluated in syngeneic immunocompetent hosts, cancer stem cell (CSC) based dendritic cell (DC) vaccine demonstrated significantly higher antitumor immunity than traditional DC vaccines pulsed with heterogeneous bulk tumor cells.

Vidéos Connexes

Read Article